<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37561665</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1545-861X</ISSN><JournalIssue CitedMedium="Internet"><Volume>72</Volume><Issue>32</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>11</Day></PubDate></JournalIssue><Title>MMWR. Morbidity and mortality weekly report</Title><ISOAbbreviation>MMWR Morb Mortal Wkly Rep</ISOAbbreviation></Journal><ArticleTitle>Long COVID and Significant Activity Limitation Among Adults, by Age - United States, June 1-13, 2022, to June 7-19, 2023.</ArticleTitle><Pagination><StartPage>866</StartPage><EndPage>870</EndPage><MedlinePgn>866-870</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.15585/mmwr.mm7232a3</ELocationID><Abstract><AbstractText>Long COVID is a condition encompassing a wide range of health problems that emerge, persist, or return following COVID-19. CDC analyzed national repeat cross-sectional Household Pulse Survey data to estimate the prevalence of long COVID and significant related activity limitation among U.S. adults aged &#x2265;18 years by age group. Data from surveys completed between June 1-13, 2022, and June 7-19, 2023, indicated that long COVID prevalence decreased from 7.5% (95% CI&#xa0;=&#xa0;7.1-7.9) to 6.0% (95% CI&#xa0;=&#xa0;5.7-6.3) among the overall U.S. adult population, irrespective of history of previous COVID-19, and from 18.9% (95% CI&#xa0;=&#xa0;17.9-19.8) to 11.0% (95% CI&#xa0;=&#xa0;10.4-11.6) among U.S. adults reporting previous COVID-19. Among both groups, prevalence decreased from June 1-13, 2022, through January 4-16, 2023, before stabilizing. When stratified by age, only adults aged &lt;60 years experienced significant rates of decline (p&lt;0.01). Among adults reporting previous COVID-19, prevalence decreased among those aged 30-79 years through fall or winter and then stabilized. During June 7-19, 2023, 26.4% (95% CI&#xa0;=&#xa0;24.0-28.9) of adults with long COVID reported significant activity limitation, the prevalence of which did not change over time. These findings help guide the ongoing COVID-19 prevention efforts and planning for long COVID symptom management and future health care service needs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ford</LastName><ForeName>Nicole D</ForeName><Initials>ND</Initials></Author><Author ValidYN="Y"><LastName>Slaughter</LastName><ForeName>Douglas</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Edwards</LastName><ForeName>Deja</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Dalton</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Perrine</LastName><ForeName>Cria</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Vahratian</LastName><ForeName>Anjel</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Saydah</LastName><ForeName>Sharon</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>MMWR Morb Mortal Wkly Rep</MedlineTA><NlmUniqueID>7802429</NlmUniqueID><ISSNLinking>0149-2195</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Douglas Slaughter reports volunteering with the Hood Medicine Initiative during the COVID-19 pandemic. No other potential conflicts of interest were disclosed.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>10</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>10</Day><Hour>13</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37561665</ArticleId><ArticleId IdType="pmc">PMC10415000</ArticleId><ArticleId IdType="doi">10.15585/mmwr.mm7232a3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nittas V, Gao M, West EA, et al. Long COVID through a public health lens: an umbrella review. Public Health Rev 2022;43:1604501. 10.3389/phrs.2022.1604501</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/phrs.2022.1604501</ArticleId><ArticleId IdType="pmc">PMC8963488</ArticleId><ArticleId IdType="pubmed">35359614</ArticleId></ArticleIdList></Reference><Reference><Citation>Tartof SY, Malden DE, Liu IA, et al. Health care utilization in the 6 months following SARS-CoV-2 infection. JAMA Netw Open 2022;5:e2225657&#x2013;2225657. 10.1001/jamanetworkopen.2022.25657</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.25657</ArticleId><ArticleId IdType="pmc">PMC9375168</ArticleId><ArticleId IdType="pubmed">35960522</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker S, Goodfellow H, Pookarnjanamorakot P, et al. Impact of fatigue as the primary determinant of functional limitations among patients with post-COVID-19 syndrome: a cross-sectional observational study. BMJ Open 2023;13:e069217. 10.1136/bmjopen-2022-069217</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-069217</ArticleId><ArticleId IdType="pmc">PMC10335413</ArticleId><ArticleId IdType="pubmed">37286327</ArticleId></ArticleIdList></Reference><Reference><Citation>Howe S, Szanyi J, Blakely T. The health impact of long COVID during the 2021&#x2013;2022 Omicron wave in Australia: a quantitative burden of disease study. Int J Epidemiol 2023;52:677&#x2013;89. 10.1093/ije/dyad033</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyad033</ArticleId><ArticleId IdType="pmc">PMC10244043</ArticleId><ArticleId IdType="pubmed">37011639</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z. Prevention of long COVID: progress and challenges. Lancet Infect Dis 2023;23:776&#x2013;7. 10.15585/mmwr.mm7117e3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7117e3</ArticleId><ArticleId IdType="pmc">PMC10162711</ArticleId><ArticleId IdType="pubmed">37156258</ArticleId></ArticleIdList></Reference><Reference><Citation>Qasmieh SA, Robertson MM, Teasdale CA, et al. The prevalence of SARS-CoV-2 infection and long COVID in U.S. adults during the BA.4/BA.5 surge, June&#x2013;July 2022. Prev Med 2023;169:107461. 10.15585/mmwr.mm7113e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7113e1</ArticleId><ArticleId IdType="pmc">PMC9940463</ArticleId><ArticleId IdType="pubmed">36813250</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchins HJ, Wolff B, Leeb R, et al. COVID-19 mitigation behaviors by age group&#x2014;United States, April&#x2013;June 2020. MMWR Morb Mortal Wkly Rep 2020;69:1584&#x2013;90. 10.1016/S1473-3099(23)00287-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00287-6</ArticleId><ArticleId IdType="pmc">PMC7641002</ArticleId><ArticleId IdType="pubmed">33119562</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Lunz Trujillo K, Safarpour A, et al. Association of post&#x2013;COVID-19 condition symptoms and employment status. JAMA Netw Open 2023;6:e2256152&#x2013;2256152. 10.1016/j.ypmed.2023.107461</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ypmed.2023.107461</ArticleId><ArticleId IdType="pmc">PMC9932847</ArticleId><ArticleId IdType="pubmed">36790806</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>